AVROBIO Inc. (AVRO) deprioritizing its Fabry disease program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. KLAC
8. CMG
9. ETSY
10. BIIB

Go back to AVROBIO Inc. (AVRO) deprioritizing its Fabry disease program

AVROBIO Reprioritizes Pipeline Programs

January 4, 2022 7:00 AM EST

Fabry disease program to be deprioritized, shifting focus to other clinical-stage programs in lysosomal disorder pipeline

Data updates for cystinosis and Gaucher disease type 1 programs planned for 1H 2022, with regulatory interactions anticipated across multiple programs in 2022

Cash runway to be extended into first quarter of 2024

CAMBRIDGE, Mass.--(BUSINESS... More